Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 76 | 2024 | 3455 | 7.490 |
Why?
|
Isocitrate Dehydrogenase | 59 | 2024 | 938 | 7.280 |
Why?
|
Brain Neoplasms | 120 | 2024 | 9031 | 6.730 |
Why?
|
Glioblastoma | 39 | 2024 | 3482 | 3.000 |
Why?
|
Oligodendroglioma | 9 | 2024 | 279 | 2.350 |
Why?
|
Mutation | 90 | 2024 | 30054 | 2.170 |
Why?
|
Astrocytoma | 14 | 2024 | 775 | 2.100 |
Why?
|
Antineoplastic Agents, Alkylating | 9 | 2020 | 617 | 1.710 |
Why?
|
Meningeal Neoplasms | 17 | 2024 | 1248 | 1.620 |
Why?
|
Glutarates | 13 | 2024 | 243 | 1.550 |
Why?
|
Meningioma | 15 | 2024 | 1218 | 1.430 |
Why?
|
Telomerase | 13 | 2024 | 745 | 1.410 |
Why?
|
Neurosurgical Procedures | 13 | 2024 | 2072 | 1.330 |
Why?
|
NAD | 6 | 2021 | 614 | 1.320 |
Why?
|
Dacarbazine | 7 | 2017 | 559 | 1.170 |
Why?
|
Central Nervous System Neoplasms | 7 | 2024 | 916 | 1.080 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2024 | 3769 | 0.970 |
Why?
|
Craniopharyngioma | 7 | 2023 | 277 | 0.960 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 7 | 2024 | 899 | 0.950 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 4 | 2020 | 83 | 0.850 |
Why?
|
Cyanides | 2 | 2020 | 82 | 0.780 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2024 | 3603 | 0.780 |
Why?
|
Molecular Targeted Therapy | 14 | 2024 | 2811 | 0.770 |
Why?
|
Guanidines | 2 | 2020 | 194 | 0.750 |
Why?
|
DNA Mismatch Repair | 3 | 2020 | 428 | 0.730 |
Why?
|
Echo-Planar Imaging | 1 | 2024 | 663 | 0.690 |
Why?
|
Glycoside Hydrolases | 1 | 2020 | 135 | 0.690 |
Why?
|
Pituitary Neoplasms | 8 | 2023 | 1324 | 0.680 |
Why?
|
Neoplasm Recurrence, Local | 20 | 2022 | 9280 | 0.670 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2024 | 5305 | 0.630 |
Why?
|
Sirtuins | 1 | 2021 | 320 | 0.600 |
Why?
|
Spinal Cord Neoplasms | 2 | 2022 | 263 | 0.580 |
Why?
|
Melanoma | 10 | 2023 | 5709 | 0.570 |
Why?
|
Phthalazines | 1 | 2020 | 383 | 0.560 |
Why?
|
Piperazines | 5 | 2024 | 2523 | 0.550 |
Why?
|
Promoter Regions, Genetic | 11 | 2024 | 5790 | 0.550 |
Why?
|
Meningeal Carcinomatosis | 3 | 2021 | 63 | 0.540 |
Why?
|
Humans | 202 | 2024 | 761572 | 0.540 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2019 | 2057 | 0.520 |
Why?
|
Mice, SCID | 8 | 2020 | 2626 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2456 | 0.500 |
Why?
|
Neurosurgery | 2 | 2021 | 679 | 0.490 |
Why?
|
Hemangioblastoma | 1 | 2014 | 62 | 0.470 |
Why?
|
Radiographic Image Enhancement | 1 | 2018 | 876 | 0.450 |
Why?
|
Enzyme Inhibitors | 5 | 2024 | 3713 | 0.430 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2019 | 2865 | 0.430 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 305 | 0.420 |
Why?
|
DNA Modification Methylases | 4 | 2020 | 210 | 0.420 |
Why?
|
Neoplasm, Residual | 5 | 2021 | 1008 | 0.400 |
Why?
|
Cell Line, Tumor | 23 | 2024 | 16986 | 0.400 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36429 | 0.400 |
Why?
|
DNA Repair Enzymes | 4 | 2020 | 346 | 0.390 |
Why?
|
Chromosome Deletion | 2 | 2015 | 1386 | 0.390 |
Why?
|
DNA-Binding Proteins | 11 | 2020 | 9610 | 0.380 |
Why?
|
Tumor Microenvironment | 11 | 2024 | 3877 | 0.370 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13642 | 0.370 |
Why?
|
DNA Repair | 1 | 2020 | 2046 | 0.350 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 3617 | 0.350 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2024 | 698 | 0.350 |
Why?
|
Fusobacterium Infections | 1 | 2010 | 53 | 0.340 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2024 | 350 | 0.340 |
Why?
|
Female | 93 | 2024 | 392686 | 0.340 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 586 | 0.340 |
Why?
|
Pathology, Molecular | 1 | 2013 | 328 | 0.340 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.340 |
Why?
|
Lymphoma | 3 | 2024 | 1901 | 0.330 |
Why?
|
Brain Abscess | 1 | 2010 | 120 | 0.330 |
Why?
|
Adult | 66 | 2024 | 221203 | 0.310 |
Why?
|
Brain | 18 | 2024 | 27120 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 6 | 2020 | 2803 | 0.310 |
Why?
|
Cytokines | 3 | 2021 | 7396 | 0.310 |
Why?
|
Middle Aged | 65 | 2024 | 220920 | 0.300 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2023 | 2057 | 0.300 |
Why?
|
Tumor Cells, Cultured | 8 | 2020 | 6132 | 0.300 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2010 | 141 | 0.300 |
Why?
|
Craniotomy | 5 | 2021 | 741 | 0.290 |
Why?
|
Prognosis | 21 | 2024 | 29629 | 0.290 |
Why?
|
Neurofibromin 2 | 3 | 2024 | 270 | 0.290 |
Why?
|
Gene Silencing | 3 | 2018 | 1509 | 0.290 |
Why?
|
Neoplastic Stem Cells | 7 | 2017 | 1349 | 0.290 |
Why?
|
Male | 79 | 2024 | 360842 | 0.280 |
Why?
|
World Health Organization | 5 | 2024 | 1322 | 0.280 |
Why?
|
Arteriovenous Malformations | 1 | 2010 | 396 | 0.280 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 368 | 0.280 |
Why?
|
Cell Proliferation | 13 | 2024 | 10448 | 0.270 |
Why?
|
Aged | 53 | 2024 | 169310 | 0.270 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2021 | 246 | 0.270 |
Why?
|
Benzimidazoles | 2 | 2024 | 858 | 0.270 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8002 | 0.260 |
Why?
|
Genotype | 4 | 2018 | 12990 | 0.260 |
Why?
|
Animals | 42 | 2024 | 168467 | 0.260 |
Why?
|
Young Adult | 28 | 2024 | 59255 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 11 | 2024 | 5672 | 0.250 |
Why?
|
Mice | 29 | 2024 | 81533 | 0.250 |
Why?
|
Streptococcal Infections | 1 | 2010 | 617 | 0.250 |
Why?
|
Aged, 80 and over | 25 | 2024 | 58986 | 0.250 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2450 | 0.240 |
Why?
|
Disease Management | 6 | 2019 | 2508 | 0.240 |
Why?
|
Genomics | 8 | 2023 | 5821 | 0.240 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2024 | 70 | 0.240 |
Why?
|
Disease Progression | 12 | 2023 | 13510 | 0.240 |
Why?
|
Foramen Magnum | 1 | 2024 | 41 | 0.230 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13382 | 0.230 |
Why?
|
Imaging, Three-Dimensional | 4 | 2024 | 4063 | 0.220 |
Why?
|
Gyrus Cinguli | 1 | 2010 | 1115 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 10 | 2020 | 6484 | 0.220 |
Why?
|
Microelectrodes | 2 | 2021 | 306 | 0.220 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11742 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2024 | 561 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2023 | 641 | 0.210 |
Why?
|
Surgery, Computer-Assisted | 2 | 2020 | 1007 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8552 | 0.210 |
Why?
|
Radiosurgery | 3 | 2019 | 1342 | 0.210 |
Why?
|
Treatment Outcome | 13 | 2024 | 64684 | 0.200 |
Why?
|
Signal Transduction | 14 | 2023 | 23447 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 4915 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 988 | 0.200 |
Why?
|
Chromosomes, Human, Pair 1 | 4 | 2018 | 638 | 0.190 |
Why?
|
Pyrimidines | 5 | 2022 | 3028 | 0.190 |
Why?
|
Oncolytic Virotherapy | 2 | 2017 | 516 | 0.180 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.180 |
Why?
|
Retrospective Studies | 26 | 2024 | 80646 | 0.180 |
Why?
|
Immune Evasion | 1 | 2024 | 363 | 0.180 |
Why?
|
Survival Rate | 8 | 2024 | 12725 | 0.180 |
Why?
|
Aminopyridines | 1 | 2024 | 573 | 0.180 |
Why?
|
Methylation | 2 | 2020 | 1084 | 0.180 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2018 | 350 | 0.180 |
Why?
|
Hexokinase | 1 | 2020 | 124 | 0.180 |
Why?
|
Motor Cortex | 2 | 2021 | 1007 | 0.170 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2021 | 198 | 0.170 |
Why?
|
Retinoblastoma Protein | 1 | 2023 | 672 | 0.170 |
Why?
|
Breast Neoplasms | 6 | 2020 | 21017 | 0.170 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 301 | 0.170 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5821 | 0.170 |
Why?
|
Sirtuin 1 | 1 | 2021 | 246 | 0.170 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 254 | 0.170 |
Why?
|
Medical Oncology | 2 | 2021 | 2321 | 0.170 |
Why?
|
Acrylamides | 2 | 2020 | 260 | 0.160 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2022 | 424 | 0.160 |
Why?
|
DNA Mutational Analysis | 8 | 2024 | 4111 | 0.160 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11076 | 0.160 |
Why?
|
Mitotic Index | 2 | 2015 | 162 | 0.160 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2018 | 42 | 0.150 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4251 | 0.150 |
Why?
|
Introns | 2 | 2017 | 981 | 0.150 |
Why?
|
DNA Helicases | 2 | 2015 | 851 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2020 | 587 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 455 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 198 | 0.150 |
Why?
|
Gene Deletion | 3 | 2024 | 2665 | 0.150 |
Why?
|
Colorectal Neoplasms | 3 | 2015 | 6935 | 0.150 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1052 | 0.140 |
Why?
|
Adolescent | 20 | 2023 | 88324 | 0.140 |
Why?
|
Follow-Up Studies | 13 | 2024 | 39107 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 129 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 592 | 0.140 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 196 | 0.140 |
Why?
|
Oxazines | 1 | 2019 | 350 | 0.140 |
Why?
|
Brain Mapping | 3 | 2021 | 6635 | 0.130 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8528 | 0.130 |
Why?
|
Pentosyltransferases | 1 | 2015 | 62 | 0.130 |
Why?
|
Mitosis | 2 | 2018 | 1188 | 0.130 |
Why?
|
Gene Amplification | 2 | 2017 | 1089 | 0.130 |
Why?
|
Simplexvirus | 2 | 2017 | 803 | 0.130 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10194 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 787 | 0.130 |
Why?
|
Glutamic Acid | 2 | 2018 | 1176 | 0.130 |
Why?
|
Neoplasms | 6 | 2024 | 22173 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4580 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 474 | 0.120 |
Why?
|
Pyridines | 2 | 2024 | 2875 | 0.120 |
Why?
|
Somatosensory Cortex | 2 | 2021 | 512 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1993 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 210 | 0.120 |
Why?
|
Intraoperative Care | 2 | 2019 | 767 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2024 | 14666 | 0.120 |
Why?
|
Thalamus | 1 | 2021 | 1047 | 0.120 |
Why?
|
Cell Differentiation | 6 | 2024 | 11530 | 0.120 |
Why?
|
Drugs, Investigational | 1 | 2016 | 212 | 0.120 |
Why?
|
Aneuploidy | 1 | 1998 | 552 | 0.120 |
Why?
|
Tumor Burden | 3 | 2018 | 1893 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2017 | 1784 | 0.120 |
Why?
|
Carcinoma, Papillary | 1 | 2019 | 785 | 0.120 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2020 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2019 | 3514 | 0.110 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 330 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1374 | 0.110 |
Why?
|
Biopsy | 4 | 2019 | 6766 | 0.110 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2021 | 1530 | 0.110 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 3688 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1835 | 0.110 |
Why?
|
Aniline Compounds | 2 | 2018 | 1069 | 0.110 |
Why?
|
Gene Targeting | 1 | 2016 | 838 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 17904 | 0.110 |
Why?
|
Electric Stimulation | 4 | 2021 | 1736 | 0.110 |
Why?
|
Speech | 1 | 2018 | 554 | 0.110 |
Why?
|
Watchful Waiting | 1 | 2017 | 491 | 0.110 |
Why?
|
NF-kappa B | 3 | 2020 | 2490 | 0.110 |
Why?
|
Histones | 3 | 2023 | 2580 | 0.100 |
Why?
|
Survival Analysis | 8 | 2021 | 10090 | 0.100 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2024 | 44 | 0.100 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.100 |
Why?
|
Mice, Nude | 4 | 2020 | 3614 | 0.100 |
Why?
|
Immunotherapy | 5 | 2022 | 4652 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2015 | 2986 | 0.100 |
Why?
|
Piperidines | 2 | 2020 | 1656 | 0.100 |
Why?
|
Prospective Studies | 7 | 2024 | 54426 | 0.100 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2023 | 1661 | 0.100 |
Why?
|
Immunity | 1 | 2018 | 996 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 634 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.100 |
Why?
|
Cell Cycle Proteins | 3 | 2023 | 3449 | 0.100 |
Why?
|
Point Mutation | 3 | 2016 | 1595 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1166 | 0.100 |
Why?
|
Nervous System Diseases | 2 | 2019 | 1667 | 0.100 |
Why?
|
Nerve Tissue Proteins | 3 | 2021 | 4415 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2024 | 3066 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 535 | 0.100 |
Why?
|
Autophagy | 2 | 2020 | 1326 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2917 | 0.100 |
Why?
|
Up-Regulation | 4 | 2024 | 4124 | 0.100 |
Why?
|
Transfection | 2 | 2015 | 5774 | 0.100 |
Why?
|
Cerebral Cortex | 2 | 2021 | 5779 | 0.090 |
Why?
|
Radiation Tolerance | 1 | 2013 | 479 | 0.090 |
Why?
|
Evoked Potentials, Motor | 1 | 2014 | 464 | 0.090 |
Why?
|
HEK293 Cells | 2 | 2020 | 4280 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1745 | 0.090 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9420 | 0.090 |
Why?
|
Temporal Lobe | 1 | 2018 | 1695 | 0.090 |
Why?
|
Streptococcus anginosus | 1 | 2010 | 24 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.090 |
Why?
|
Transcription Factors | 5 | 2023 | 12129 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2016 | 1420 | 0.090 |
Why?
|
Blast Crisis | 1 | 2010 | 102 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2015 | 3597 | 0.080 |
Why?
|
Epigenomics | 1 | 2015 | 943 | 0.080 |
Why?
|
Tumor Escape | 2 | 2024 | 370 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1545 | 0.080 |
Why?
|
Cell Cycle | 4 | 2019 | 2932 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1962 | 0.080 |
Why?
|
Cell Lineage | 4 | 2024 | 2556 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2020 | 12794 | 0.080 |
Why?
|
Epistaxis | 1 | 2010 | 112 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 971 | 0.080 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6815 | 0.080 |
Why?
|
Polymerase Chain Reaction | 4 | 2020 | 6075 | 0.080 |
Why?
|
Sindbis Virus | 1 | 1989 | 36 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2827 | 0.080 |
Why?
|
Quinolines | 1 | 2014 | 764 | 0.080 |
Why?
|
Homozygote | 2 | 2024 | 1776 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 1897 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3290 | 0.080 |
Why?
|
Chlorpromazine | 1 | 1989 | 111 | 0.080 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1989 | 93 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6237 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1405 | 0.080 |
Why?
|
Receptors, Somatostatin | 1 | 2009 | 136 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1051 | 0.080 |
Why?
|
Fusobacterium nucleatum | 1 | 2010 | 179 | 0.080 |
Why?
|
Language | 1 | 2018 | 1540 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.080 |
Why?
|
Verapamil | 1 | 1989 | 242 | 0.080 |
Why?
|
Mosaicism | 1 | 2011 | 475 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2015 | 1589 | 0.080 |
Why?
|
DNA Methylation | 5 | 2024 | 4399 | 0.080 |
Why?
|
Genetic Heterogeneity | 3 | 2019 | 732 | 0.080 |
Why?
|
Psychomotor Performance | 1 | 2016 | 1882 | 0.080 |
Why?
|
Fibroblasts | 2 | 2016 | 4141 | 0.070 |
Why?
|
Nausea | 2 | 2021 | 679 | 0.070 |
Why?
|
Apoptosis | 6 | 2019 | 9489 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1392 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2011 | 571 | 0.070 |
Why?
|
Spinal Cord | 1 | 2016 | 1819 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2014 | 942 | 0.070 |
Why?
|
Muscle Weakness | 1 | 2010 | 412 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2226 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1740 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 1092 | 0.070 |
Why?
|
Memory | 1 | 2016 | 2193 | 0.070 |
Why?
|
Cytomegalovirus | 1 | 2011 | 756 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4740 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3396 | 0.070 |
Why?
|
Metabolomics | 1 | 2015 | 1659 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2332 | 0.070 |
Why?
|
Vertebral Artery Dissection | 1 | 2006 | 51 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4513 | 0.070 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3801 | 0.070 |
Why?
|
Seizures | 1 | 2019 | 2957 | 0.070 |
Why?
|
Histone Demethylases | 2 | 2020 | 323 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2396 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 12975 | 0.060 |
Why?
|
Protein Kinases | 4 | 2016 | 1608 | 0.060 |
Why?
|
Virus Replication | 2 | 2016 | 2435 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18253 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7858 | 0.060 |
Why?
|
Prostate | 2 | 2023 | 1773 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 370 | 0.060 |
Why?
|
Adenoma | 2 | 2020 | 2160 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2024 | 2644 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11121 | 0.060 |
Why?
|
Child, Preschool | 7 | 2023 | 42230 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2015 | 2882 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 822 | 0.060 |
Why?
|
Glycolysis | 2 | 2020 | 835 | 0.060 |
Why?
|
Proteins | 1 | 1999 | 6032 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2010 | 743 | 0.060 |
Why?
|
Cohort Studies | 4 | 2020 | 41493 | 0.060 |
Why?
|
Migraine with Aura | 1 | 2006 | 204 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2018 | 3980 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4346 | 0.060 |
Why?
|
RNA Polymerase III | 1 | 2024 | 58 | 0.060 |
Why?
|
DNA Copy Number Variations | 3 | 2020 | 2020 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7054 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2004 | 178 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4878 | 0.050 |
Why?
|
Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
Receptors, Notch | 2 | 2018 | 743 | 0.050 |
Why?
|
Algorithms | 2 | 2024 | 14032 | 0.050 |
Why?
|
Child | 9 | 2023 | 80156 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1469 | 0.050 |
Why?
|
Imidazoles | 2 | 2015 | 1180 | 0.050 |
Why?
|
Consensus | 2 | 2023 | 3123 | 0.050 |
Why?
|
Genetic Variation | 2 | 2015 | 6567 | 0.050 |
Why?
|
Brain Edema | 1 | 2007 | 604 | 0.050 |
Why?
|
Time Factors | 5 | 2017 | 39970 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 244 | 0.050 |
Why?
|
Pediatrics | 1 | 2017 | 3589 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 186 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5315 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9463 | 0.050 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2001 | 18 | 0.050 |
Why?
|
Monocytes | 1 | 2011 | 2570 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 55 | 0.050 |
Why?
|
Phylogeny | 2 | 2021 | 2811 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1927 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2024 | 496 | 0.050 |
Why?
|
Osteitis Deformans | 1 | 2001 | 54 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 154 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2024 | 504 | 0.050 |
Why?
|
DNA | 3 | 2024 | 7213 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 364 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5882 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 9002 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 755 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 318 | 0.040 |
Why?
|
Quinazolines | 1 | 2007 | 1371 | 0.040 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 102 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5247 | 0.040 |
Why?
|
Exons | 2 | 2011 | 2391 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13446 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2020 | 280 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 228 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 823 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 563 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 307 | 0.040 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 196 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1494 | 0.040 |
Why?
|
Genome, Human | 2 | 2016 | 4425 | 0.040 |
Why?
|
Tretinoin | 1 | 2022 | 519 | 0.040 |
Why?
|
Benzamides | 2 | 2018 | 1370 | 0.040 |
Why?
|
Physical Chromosome Mapping | 1 | 1999 | 183 | 0.040 |
Why?
|
Blotting, Western | 3 | 2017 | 5035 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1745 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
Vision Disorders | 1 | 2006 | 1088 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Diphenylamine | 1 | 2018 | 49 | 0.040 |
Why?
|
Carcinogens | 1 | 2001 | 452 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 390 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4853 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 17635 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2001 | 784 | 0.040 |
Why?
|
Infant | 4 | 2023 | 36192 | 0.040 |
Why?
|
Demecolcine | 1 | 1998 | 18 | 0.040 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.040 |
Why?
|
DNA Primers | 2 | 2001 | 2819 | 0.040 |
Why?
|
Nocodazole | 1 | 1998 | 95 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 555 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3430 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9177 | 0.040 |
Why?
|
Neoadjuvant Therapy | 2 | 2019 | 2827 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3639 | 0.040 |
Why?
|
Polyamines | 1 | 2018 | 133 | 0.040 |
Why?
|
Base Sequence | 3 | 2016 | 12441 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1136 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 585 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 293 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2015 | 2707 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2397 | 0.040 |
Why?
|
Observer Variation | 1 | 2023 | 2606 | 0.040 |
Why?
|
Quinazolinones | 1 | 2019 | 221 | 0.040 |
Why?
|
Thoracic Vertebrae | 1 | 2001 | 597 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13367 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22172 | 0.040 |
Why?
|
Phonetics | 1 | 2018 | 198 | 0.030 |
Why?
|
Triazoles | 1 | 2022 | 903 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 651 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 962 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
Patient Selection | 2 | 2019 | 4244 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1235 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2018 | 277 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1336 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 858 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 389 | 0.030 |
Why?
|
Astrocytes | 1 | 2024 | 1346 | 0.030 |
Why?
|
Drug Carriers | 1 | 2020 | 706 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 352 | 0.030 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 171 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15936 | 0.030 |
Why?
|
Cell Movement | 3 | 2020 | 5205 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5799 | 0.030 |
Why?
|
Water | 1 | 2021 | 1411 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2001 | 897 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2748 | 0.030 |
Why?
|
Spinal Fractures | 1 | 2001 | 705 | 0.030 |
Why?
|
Survival | 1 | 2015 | 161 | 0.030 |
Why?
|
Fracture Fixation, Internal | 1 | 2001 | 973 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5769 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2329 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 629 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1218 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 510 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1552 | 0.030 |
Why?
|
Semantics | 1 | 2018 | 613 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20099 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1229 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2003 | 2469 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Valine | 1 | 2015 | 408 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1618 | 0.030 |
Why?
|
Bullying | 1 | 2017 | 232 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 945 | 0.030 |
Why?
|
Skull Base | 1 | 2016 | 292 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1612 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10766 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1574 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
Radiation Oncology | 1 | 2019 | 563 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 353 | 0.030 |
Why?
|
Polymers | 1 | 2020 | 1617 | 0.030 |
Why?
|
Glycoproteins | 1 | 2001 | 2203 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3162 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16592 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 385 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1233 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2014 | 2510 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3492 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1802 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 918 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 621 | 0.030 |
Why?
|
Empathy | 1 | 2017 | 473 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4174 | 0.030 |
Why?
|
Baclofen | 1 | 1993 | 120 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2231 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15266 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1529 | 0.030 |
Why?
|
Lysine | 1 | 2016 | 993 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2001 | 1879 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10212 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 1989 | 0.020 |
Why?
|
Muscle Spasticity | 1 | 1993 | 156 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3826 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 934 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2201 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3272 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1376 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2822 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1040 | 0.020 |
Why?
|
Magnetics | 1 | 2014 | 599 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2919 | 0.020 |
Why?
|
Receptor, Notch2 | 1 | 2011 | 87 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2020 | 2526 | 0.020 |
Why?
|
Risk Factors | 5 | 2021 | 74213 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2018 | 953 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 956 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1626 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2011 | 363 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 809 | 0.020 |
Why?
|
Spinal Cord Diseases | 1 | 1993 | 292 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1027 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 2012 | 390 | 0.020 |
Why?
|
Models, Genetic | 1 | 1999 | 3442 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4369 | 0.020 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 397 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 888 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2547 | 0.020 |
Why?
|
Risk Assessment | 3 | 2021 | 23996 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 662 | 0.020 |
Why?
|
Ependymoma | 1 | 2012 | 320 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12463 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 1998 | 1228 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2011 | 439 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1978 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1858 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4243 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2001 | 2529 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2726 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2449 | 0.020 |
Why?
|
Viral Core Proteins | 1 | 1989 | 161 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1222 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1361 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2010 | 5869 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1410 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2009 | 618 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5485 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3323 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1999 | 2538 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1062 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 3359 | 0.020 |
Why?
|
Chick Embryo | 1 | 1989 | 982 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3080 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10553 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9646 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 1741 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.020 |
Why?
|
Capsid | 1 | 1989 | 435 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1596 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 18965 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2012 | 1264 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2521 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2601 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2009 | 716 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2011 | 1175 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3882 | 0.020 |
Why?
|
Scotoma | 1 | 2006 | 130 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7581 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18398 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2007 | 422 | 0.020 |
Why?
|
Calcium | 1 | 2018 | 5722 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1993 | 925 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2007 | 454 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2011 | 831 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9353 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.010 |
Why?
|
Databases, Factual | 1 | 1999 | 7967 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8633 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 664 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1990 | 1349 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14416 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7593 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1990 | 1784 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2571 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20571 | 0.010 |
Why?
|
Viral Proteins | 1 | 1989 | 1804 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4811 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11122 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2007 | 867 | 0.010 |
Why?
|
Osteoprotegerin | 1 | 2001 | 176 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26198 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2007 | 946 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2006 | 1432 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3810 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5791 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7879 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12059 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 585 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2001 | 1045 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1989 | 3701 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2003 | 1440 | 0.010 |
Why?
|
Sex Distribution | 1 | 2001 | 2281 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12690 | 0.010 |
Why?
|
Age Distribution | 1 | 2001 | 2880 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2004 | 1712 | 0.010 |
Why?
|
Liver | 1 | 1990 | 7529 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 3548 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 1993 | 158 | 0.010 |
Why?
|
Injections, Spinal | 1 | 1993 | 318 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1993 | 367 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1990 | 295 | 0.000 |
Why?
|
Genetic Testing | 1 | 2001 | 3537 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 898 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1990 | 1762 | 0.000 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1990 | 1351 | 0.000 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1990 | 1435 | 0.000 |
Why?
|
Decision Making | 1 | 1998 | 3929 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1990 | 1560 | 0.000 |
Why?
|
Incidence | 1 | 2001 | 21355 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7407 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1993 | 12341 | 0.000 |
Why?
|
Liver Transplantation | 1 | 1990 | 2330 | 0.000 |
Why?
|
Multiple Sclerosis | 1 | 1993 | 3220 | 0.000 |
Why?
|